Abstract:Despite the effective use of antiepileptic drugs (AEDs) for epilepsy, therapeutic failure occurs in 30% of patients. Novel approaches are targeting the inhibition of epileptogenesis. N-acetyl-5-methoxytryptamine (melatonin) is an indoleamine produced mainly by the pineal gland, and has been observed to exhibit antiepileptic and neuroprotective effects in experimental and clinical investigations. In the present study, the underlying protective mechanism of melatonin on neonatal seizure-induced long-term excitotoxicity was examined in the hippocampus of rats, predominantly on the metabolism-associated genes. Sprague Dawley rats (6-day-old; P6) were randomly divided into four groups, the control (Cont), melatonin-treated control (Mel), recurrent neonatal seizure (RS) and treatment with melatonin and RS combined (Mel+RS). At P35, mossy fiber sprouting and changes in gene expression in hippocampus were assessed using Timm staining, reverse transcription-quantitative polymerase chain reaction and use of the 2(-ΔCT) methods, respectively. The aberrant mossy fiber sprouting in the supra granular region of the dentate gyrus and CA3 subfield of the hippocampus was suppressed by pretreatment with melatonin. In addition, among the nineteen genes identified, four energy metabolism-associated genes (Kcnj11, leptin receptor, dopamine receptor D2 and melanocortin 4 receptor), four lipid metabolism-associated genes (apolipoprotein A-I, opioid receptor κ 1, pyruvate dehydrogenase kinase, isozyme 4 and cytochrome P450, family 46, subfamily a, polypeptide 1) and zinc transporter 1 (ZnT1), sphingomyelinase (nSMase) and Cathepsin-E, were markedly downregulated by melatonin treatment in the Mel group or in the developmental seizure RS and Mel + RS groups, compared with that in the Cont group. Furthermore, the melatonin-pretreated seizure rats (Mel + RS) exhibited a significantly upregulated expression of calcium/calmodulin-dependent protein kinase II α (CaMKIIα), acetyl-Coenzyme A acetyltransferase 1 (ACAT1), ZnT-1, metallothionein 1 (MT-1), nSMase and Cathepsin-E, compared with the RS rats. Thus, the present study investigated changes in the expression of metabolic genes in the hippocampus following pretreatment with melatonin. Fluorthyl-induced decreases in the expression levels of ACAT1/nSMase/Cathepsin-E, ZnT-1/MT-1 and CaMKIIα in the hippocampus, and the reversal by melatonin may be associated with a decrease in neonatal seizure-induced aberrant mossy fiber sprouting, which requires further investigation.

Melatonin Influences Structural Plasticity in the Axons of Granule Cells in the Dentate Gyrus of Balb/C Mice

Melatonin Modulates Dendrite Maturation and Complexity in the Dorsal- and Ventral- Dentate Gyrus Concomitantly with Its Antidepressant-Like Effect in Male Balb/C Mice

Melatonin alters neuronal architecture and increases cysteine‐rich protein 1 signaling in the male mouse hippocampus

Melatonin Reverses the Depression-associated Behaviour and Regulates Microglia, Fractalkine Expression and Neurogenesis in Adult Mice Exposed to Chronic Mild Stress

Chronic administration of a melatonin membrane receptor antagonist, luzindole, affects hippocampal neurogenesis without changes in hopelessness-like behavior in adult mice

Melatonin Arrests Peroxynitrite-Induced Tau Hyperphosphorylation And The Overactivation Of Protein Kinases In Rat Brain

Dietary Melatonin Attenuates Age-Related Changes in Morphology and in Levels of Key Proteins in Globus Pallidus of Mouse Brain

Melatonin attenuates methamphetamine-induced inhibition of neurogenesis in the adult mouse hippocampus: An in vivo study

Homeostatic Shrinkage of Dendritic Spines Requires Melatonin Type 3 Receptor Activation During Sleep

Melatonin Modulates the GABAergic Response in Cultured Rat Hippocampal Neurons.

Long-Term Expression of Metabolism-Associated Genes in the Rat Hippocampus Following Recurrent Neonatal Seizures and Its Regulation by Melatonin

Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats

Deregulation of Melatonin Receptors and Differential Modulation of After‐Hyperpolarization and Ih Currents Using Melatonin Treatment Due to Amyloid‐β‐Induced Neurotoxicity in the Hippocampus

Melatonin treatment mimics the antidepressant action in chronic corticosterone‐treated mice

Melatonin mitigates manganese-induced neural damage via modulation of gut microbiota-metabolism in mice

Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice

Melatonin Decreases Acute Inflammatory Response to Neural Probe Insertion

Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ1-42 Infusion

Effects of Melatonin and Its Analogues on Neural Stem Cells.

Developmental effect of light deprivation on synaptic plasticity of rats' hippocampus: implications for melatonin

Melatonin attenuates dexamethasone-induced spatial memory impairment and dexamethasone-induced reduction of synaptic protein expressions in the mouse brain